“While this action limits the amount of available vaccine, its impact on the Fairfax Health District is minimal since the Fairfax County Health Department and its partners have primarily been using Pfizer vaccine for the past several months,” the county health department wrote in a blog post.
The county health department says this latest setback does not affect any of its clinics or appointments, and the “small amount” of the J&J vaccine that was being used will be substituted with the other vaccines.
“Fairfax County did not receive any J&J vaccine this week, and we were not expecting any next week. A small amount of J&J vaccine remaining from last week and allocated for this week will be substituted with Pfizer and Moderna vaccines to avoid any cancellations at our Health Department sites,” the county said.
They also advise those who did receive the J&J vaccine to contact their health provider if they develop a severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination.
The Centers for Disease Control and Prevention and the Food and Drug Administration recommended this morning (Tuesday) that use of the J&J vaccine be paused while they review reports that six recipients, all women, developed a rare disorder involving blood clots after taking the vaccine.
In total, more than 6.8 million doses of the vaccine has been administered across the country, and the FDA is classifying the adverse, though dangerous, reactions as “extremely rare.”
The CDC and FDA say their recommendation comes “out of abundance of caution” so that further review and study can be done.
Gov. Ralph Northam announced just before 9 a.m. that Virginia would follow the federal government’s guidance and temporarily pause its use of the J&J vaccine until an investigation is complete.
“This pause is reassuring in that it demonstrates that the systems that are in place to monitor vaccine safety are working,” Virginia Vaccination Coordinator Dr. Danny Avula said in a statement. “We look forward to a thorough review by federal health officials.”
This is the second snag that the Johnson & Johnson vaccine has hit in the past two weeks after a production mess-up at a Baltimore manufacturing plant contaminated as many as 15 million doses.
As a result, many states, including Virginia, have had their vaccine orders significantly cut. Virginia was expected to receive only about one-tenth of the number of doses of the J&J vaccine this coming week than the previous week.
Fairfax County Board of Supervisors Chairman Jeff McKay told Reston Now that the county did not anticipate getting any of the Johnson and Johnson vaccine this week or next week due to that supply shortage.
“The possible side effects of the vaccine are concerning for our national vaccination efforts because they [are] significantly dependent on the Johnson and Johnson vaccine,” McKay said. “At the end of the day however, safety and efficacy is most important and we are lucky we have two great vaccine options still available.
Earlier this month, Fairfax County committed to the same goal as the Commonwealth in having everyone over the age of 16 be eligible for the vaccine starting April 18. However, that was contingent on there being a sufficient supply.
Northam reiterated during a press conference outside Metz Middle School in Manassas, which hosted a vaccination clinic today, that Virginia still hopes that all adults who want to get vaccinated will receive their first dose by the end of May.
“Hopefully, this is just a small setback that we’ll overcome,” Northam said.
Angela Woolsey contributed to this report.
Photo by Karen Bolt/Fairfax County Public Schools